The Malaria Consortium is a leading non-profit organization that works tirelessly to prevent and treat malaria, particularly in sub-Saharan Africa and Asia. The Consortium's primary focus is on children under five years old, who are most vulnerable to the disease. The organization distributes anti-malarial drugs during the highest transmission season, with doses given monthly. An estimated 56% of program participants receive all four months of treatments, with the average cost for the four-month dosage program being $6.59 per child. The Malaria Consortium's work is crucial in the fight against malaria, a disease that causes significant child mortality rates. However, the organization's efforts could be scaled up with more funding. A donation of $26 can provide a child with malaria prevention treatment for an entire year. While other organizations like the Against Malaria Foundation and Helen Keller International also do commendable work in their respective areas, the Malaria Consortium stands out for its targeted, cost-effective approach to malaria prevention and treatment. This is where Daffy comes in. As a Donor-Advised Fund (DAF), Daffy provides a flexible and efficient way to manage charitable giving. By choosing Daffy as your DAF, you can support the Malaria Consortium's vital work and help protect more children from this deadly disease. Your contribution could make a significant difference in the fight against malaria, making Daffy a great option for your charitable giving.